
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
The U.S. Preventive Services Task Force (USPSTF) is seeking public comment on its draft recommendation on adult screening for hepatitis C virus (HCV) until Dec. 24, the agency announced.






